BusinessAmerican College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps RepealBy Nasdaq OMXFeb 9, 2018, 4:03 PM UTC
BusinessRheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and CompetitionBy Nasdaq OMXJan 30, 2018, 7:13 PM UTC
Business109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug CostsBy Nasdaq OMXJan 18, 2018, 8:43 PM UTC
BusinessHorizon Pharma plc Presents New Data at 2017 ACR/ARHP Annual Meeting, Advances Clinical Understanding of KRYSTEXXA® (pegloticase injection) in Adults with Uncontrolled GoutBy Nasdaq OMXNov 6, 2017, 5:00 PM UTC
BusinessHorizon Pharma plc Announces Poster Presentation on KRYSTEXXA® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017By Nasdaq OMXNov 3, 2017, 3:00 PM UTC
BusinessKonica Minolta Demonstrates Rheumatology Reporting Package for Ultrasound at ACR/ARHP Annual MeetingBy Nasdaq OMXNov 2, 2017, 4:15 PM UTC
BusinessHorizon Pharma plc to Present KRYSTEXXA® (pegloticase injection) Data for the Management of Uncontrolled Gout at the 2017 ACR/ARHP Annual MeetingBy Nasdaq OMXOct 23, 2017, 12:01 PM UTC
BusinessArthritis Advocates Urge Congress to Take Action to Address Drug Costs, Access IssuesBy Nasdaq OMXSep 26, 2017, 4:00 PM UTC
